Cited by 481PI3K/AKT/mTOR signaling in cancerSignaling Pathways in DiseaseFungal and yeast genetics research

RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.

Open access
Chiu, M I, Katz, H, Berlin, V·1994·Proceedings of the National Academy of Sciences

Abstract

Rapamycin is a potent immunosuppressant that blocks the G1/S transition in antigen-activated T cells and in yeast. The similar effects of rapamycin in animal cells and yeast suggest that the biochemical steps affected by rapamycin are conserved. Using a two-hybrid system we isolated mammalian clones that interact with the human FK506/rapamycin-binding protein (FKBP12) in the presence of rapamycin. Specific interactors, designated RAPT1, encode overlapping sequences homologous to yeast Tor, a putative novel phosphatidylinositol 3-kinase. A region of 133 amino acids of RAPT1 is sufficient for binding to the FKBP12/rapamycin complex. The corresponding region in yeast Tor contains the serine residue that when mutated to arginine confers resistance to rapamycin. Introduction of this mutation into RAPT1 abolishes its interaction with the FKBP12/rapamycin complex.

Integrity signals

Registry

Crossref · 10.1073/pnas.91.26.12574

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The mTOR kinase N-lobe features a large insertion corresponding to the FKBP12-rapamycin binding (FRB) domain specific to mTORC1 among the PIKKs.

    “Notably, however, the kinase N-lobe features a large insertion corresponding to the FKBP12-rapamycin binding (FRB) domain (Chen et al., 1995; Chiu et al., 1994; Vilella-Bach et al., 1999) specific to mTORC1 among the PIKKs.”

    From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as Chiu et al., 1994

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chiu, M. I., Katz, H., & Berlin, V
Affiliations
Mitotix, Inc., Cambridge, MA 02139.
Venue
Proceedings of the National Academy of Sciences
Published
1994-12-20
Volume
91
Issue
26
Pages
12574-12578
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2120356140
Cited by
481
References
30
Citations by year
2026: 7 · 2025: 4 · 2024: 9 · 2023: 5 · 2022: 12 · 2021: 14 · 2020: 13 · 2019: 9 · 2018: 14 · 2017: 17 · 2016: 17 · 2015: 13 · 2014: 10 · 2013: 20 · 2012: 12
FWCI
5.32
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Keywords
TOR kinase, FKBP12, rapamycin, protein-protein interaction, phosphatidylinositol 3-kinase, G1/S transition, T cell activation, rapamycin resistance, conserved signaling pathways, yeast homolog
MeSH terms
Amino Acid Sequence, Animals, Base Sequence, Carrier Proteins, Cloning, Molecular, DNA-Binding Proteins, Heat-Shock Proteins, Molecular Sequence Data, Polyenes, Protein Binding, RNA, Messenger, Structure-Activity Relationship, Tissue Distribution, Gene Expression, Mutagenesis, Site-Directed, Sequence Alignment, Sequence Homology, Amino Acid, Phosphotransferases (Alcohol Group Acceptor), DNA Primers, Phosphatidylinositol 3-Kinases, Sirolimus, Tacrolimus Binding Proteins, Macromolecular Substances, Mice, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review